We are live on ! Find out more
FCOMV

Foresite Capital Opportunity Management V Portfolio holdings

AUM $33.3M
1-Year Est. Return 47.04%
This Fund
S&P 500
This Quarter Est. Return
-43.82%
1 Year Est. Return
-47.04%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.4M
AUM Growth
-$77.7M
Cap. Flow
-$7.21M
Cap. Flow %
-10.09%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
ENTA icon
Enanta Pharmaceuticals
ENTA
+$1.48M

Top Sells

Rank Stock Value
1
HLTH
Cue Health Inc. Common Stock
HLTH
+$8.01M
2
CGEM icon
Cullinan Oncology
CGEM
+$678K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$37.7M 52.85%
5,227,307
– –
QSI icon
2
Quantum-Si Incorporated
QSI
$176M
$7.48M 10.47%
1,598,125
– –
THRX
3
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$5.41M 7.57%
468,820
– –
HLTH
4
DELISTED
Cue Health Inc. Common Stock
HLTH
$4.14M 5.79%
641,483
-885,620
-58% -$8.01M
CGEM icon
5
Cullinan Oncology
CGEM
$1.45B
$3.46M 4.85%
330,836
-50,166
-13% -$678K
ACET icon
6
Adicet Bio
ACET
$84.3M
$3.4M 4.75%
10,625
– –
IRON icon
7
Disc Medicine
IRON
$3.17B
$3.38M 4.74%
81,171
– –
KNTE
8
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$3.28M 4.6%
291,667
– –
ENTA icon
9
Enanta Pharmaceuticals
ENTA
$402M
$1.62M 2.27%
+22,750
New +$1.48M
CMPX icon
10
Compass Therapeutics
CMPX
$454M
$1.51M 2.11%
1,100,000
– –

Similar funds

SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return

Foresite Capital Opportunity Management V's Q1 2022 Portfolio in Review

As of Q1 2022, Foresite Capital Opportunity Management V held 10 positions worth $71.4M, down 52% from $149M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Opportunity Management V withdrew a net $7.21M in Q1 2022, reducing 2 holdings. Its largest reduction was Cue Health Inc. Common Stock, cutting an estimated $8.01M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Foresite Capital Opportunity Management V opened a new position in Enanta Pharmaceuticals worth $1.62M.

  • Foresite Capital Opportunity Management V's largest Q1 2022 buy was Enanta Pharmaceuticals: 22,750 shares worth $1.62M.
  • Foresite Capital Opportunity Management V's biggest Q1 2022 reduction was Cue Health Inc. Common Stock, cutting an estimated $8.01M.
  • Foresite Capital Opportunity Management V's ten largest holdings make up 100% of its $71.4M portfolio in Q1 2022.
  • Foresite Capital Opportunity Management V opened 1 new position and closed 0 in Q1 2022.
  • Foresite Capital Opportunity Management V's portfolio value fell 52% quarter-over-quarter to $71.4M.

Based on Foresite Capital Opportunity Management V's 13F filing for Q1 2022, filed 13 May 2022.